Kenvue Inc (KVUE)

NYSE
Currency in USD
24.00
-0.44(-1.80%)
Closed·
Pre Market
24.000.00(0.00%)
·
KVUE Scorecard
Full Analysis
Net income is expected to grow this year
KVUE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.9024.61
52 wk Range
17.6725.17
Key Statistics
Edit
Prev. Close
24
Open
24.26
Day's Range
23.9-24.61
52 wk Range
17.67-25.17
Volume
15.04M
Average Vol. (3m)
18.12M
1-Year Change
16.85%
Book Value / Share
5.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KVUE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.75
Upside
+3.14%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Kenvue Inc Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Kenvue Inc SWOT Analysis


Brand Powe
Learn how Kenvue leverages its portfolio of established brands to potentially expand market share and capitalize on emerging trends in consumer health
Financial Outlook
Analysts project EPS around $1.15, with price targets ranging from $21 to $27. Management aims for 3-4% sales growth and a 3.5% dividend yield
Market Challenges
Delve into Kenvue's struggle to maintain market share, particularly in the Skin Health & Beauty segment, amid fierce competition in consumer health
Strategic Shift
Explore Kenvue's "Extraordinary Powers" strategy, designed to drive growth and operational efficiency as the company navigates its first year of independence
Read full SWOT analysis

Kenvue Inc Earnings Call Summary for Q1/2025

  • Kenvue's Q1 2025 EPS of $0.24 and revenue of $3.74B exceeded forecasts, driving a 6.01% stock surge in premarket trading
  • Despite a 1.2% YoY organic sales decline, Kenvue maintained market leadership in key categories like Tylenol and Neutrogena
  • Company reaffirms 2-4% organic sales growth outlook for 2025, with growth acceleration expected in the latter half of the year
  • Strategic focus on innovation, supply chain resilience, and preserving brand health amid market challenges and tariff impacts
  • Executives anticipate flat YoY adjusted diluted EPS, 1% currency drag on top-line, and $150M gross tariff impact for 2025
Last Updated: 05/08/2025, 09:13 AM
Read Full Transcript

Compare KVUE to Peers and Sector

Metrics to compare
KVUE
Peers
Sector
Relationship
P/E Ratio
43.6x24.6x11.6x
PEG Ratio
−1.490.720.03
Price / Book
4.6x3.2x1.5x
Price / LTM Sales
3.0x2.1x0.9x
Upside (Analyst Target)
0.7%43.0%18.0%
Fair Value Upside
Unlock1.3%10.6%Unlock

Analyst Ratings

4 Buy
14 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 24.75
(+3.14% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.55%
Dividend Yield
3.36%
Industry Median 2.14%
Annualized Payout
0.82
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 08, 2025
EPS / Forecast
0.24 / 0.23
Revenue / Forecast
3.74B / 3.68B
EPS Revisions
Last 90 days

People Also Watch

102.87
BSX
+0.01%
92.32
ANET
+6.70%
102.04
FTNT
+4.74%
136.67
KMB
+2.72%
123.00
NVDA
+5.44%

FAQ

What Is the Kenvue (KVUE) Stock Price Today?

The Kenvue stock price today is 24.00

What Stock Exchange Does Kenvue Trade On?

Kenvue is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Kenvue?

The stock symbol for Kenvue is "KVUE."

Does Kenvue Pay Dividends? What’s The Current Dividend Yield?

The Kenvue dividend yield is 3.42%.

What Is the Kenvue Market Cap?

As of today, Kenvue market cap is 46.08B.

What Is Kenvue's Earnings Per Share (TTM)?

The Kenvue EPS (TTM) is 0.55.

When Is the Next Kenvue Earnings Date?

Kenvue will release its next earnings report on Jul 17, 2025.

From a Technical Analysis Perspective, Is KVUE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.